Promises about data security are easy to make and impossible to verify. Ours are in the software. The software runs in the country. Atlas, Prism and Phylax are being built to their filed specifications. All three are the subject of United States provisional patent applications filed in July 2026. Patent pending.
Holds raw signal, alignments and variants on in-country infrastructure only. A researcher's question is answered by a governed retrieval plan executed inside the environment; only the result leaves, after automatic disclosure control. Every item of data carries a provenance ledger.
For a country: international science on national data without export; any result traceable to the consented data it came from.
Admits each analysis only against purpose, consent tier and entitlement; meters a disclosure budget; issues a verifiable provenance certificate for every output; tests any exported model for memorised data and blocks it; logs every action to a hash-linked ledger the State can verify. A withdrawn consent revokes every certificate bound to it.
For a country: control that persists after a result has left. A door-guarding system cannot do that. The operator cannot rewrite history undetected. Neither can we.
Keeps every audience-specific output (a regulator's dossier, a partner's dashboard, a ministry's report) consistent with one versioned body of evidence. A change in the data is detected and propagated. It is never quietly lost.
For a country: a minister, an ethics committee and a research partner see the same evidence. It is rendered for each, and it is current.
Who decides, who checks. A national-majority Data Access Committee approves every use; an independent Governance and Ethics Board oversees; two audits are published; the State verifies the ledger itself. LydiaRx is bound by the same controls as every partner.
Our early phases run on established, licensed compute-to-data infrastructure. Atlas, Phylax and Prism deploy on top of that substrate as each reaches production. The substrate is not ours, and we say so. The governance, custody, metering and rendering layer is.
LydiaRx specifies whole-genome long-read sequencing at 30×. Long reads resolve the structural variants and repeat expansions that short-read technology mismaps. They also read DNA methylation natively. From the cohort's own phased haplotypes we build a population-specific reference. This is a pangenome graph, with telomere-to-telomere (T2T) assemblies where a programme calls for them. South Asian or Arab genomes are no longer forced through a European-anchored reference that hides their variation.
We give architecture briefings to government technical teams, national laboratories and infrastructure providers.